HC Wainwright Reaffirms “Buy” Rating for Unity Biotechnology (NASDAQ:UBX)
HC Wainwright restated their buy rating on shares of Unity Biotechnology (NASDAQ:UBX – Free Report) in a report published on Tuesday morning, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. HC Wainwright also issued estimates for Unity Biotechnology’s Q4 2023 earnings at ($1.15) EPS, FY2024 earnings at ($3.83) EPS, FY2025 […]
More Stories
O Shaughnessy Asset Management LLC Purchases 1,308 Shares of Samsara Inc. (NYSE:IOT)
O Shaughnessy Asset Management LLC increased its stake in Samsara Inc. (NYSE:IOT – Free Report) by 11.3% in the fourth...
O Shaughnessy Asset Management LLC Purchases 1,308 Shares of Samsara Inc. (NYSE:IOT)
O Shaughnessy Asset Management LLC increased its stake in Samsara Inc. (NYSE:IOT – Free Report) by 11.3% in the fourth...
Wellington Management Group LLP Boosts Holdings in The Vita Coco Company, Inc. (NASDAQ:COCO)
Wellington Management Group LLP lifted its stake in shares of The Vita Coco Company, Inc. (NASDAQ:COCO – Free Report) by...
Wellington Management Group LLP Boosts Holdings in The Vita Coco Company, Inc. (NASDAQ:COCO)
Wellington Management Group LLP lifted its stake in shares of The Vita Coco Company, Inc. (NASDAQ:COCO – Free Report) by...
Pictet Asset Management Holding SA Purchases 2,886 Shares of Oceaneering International, Inc. (NYSE:OII)
Pictet Asset Management Holding SA raised its stake in Oceaneering International, Inc. (NYSE:OII – Free Report) by 22.0% during the...
Pictet Asset Management Holding SA Purchases 2,886 Shares of Oceaneering International, Inc. (NYSE:OII)
Pictet Asset Management Holding SA raised its stake in Oceaneering International, Inc. (NYSE:OII – Free Report) by 22.0% during the...